Lyell Immunopharma, Inc. announced that on June 1, 2023, Rahsaan Thompson the Company of his decision to resign from his current position as the Chief Legal Officer of the Company, effective June 16, 2023. There were no disagreements between Mr. Thompson and the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.665 USD | -0.19% | +4.33% | +36.60% |
05-06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
05-06 | Lyell Immunopharma Shares Rise After Q1 Net Loss Narrows | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.60% | 681M | |
+7.57% | 115B | |
+12.72% | 107B | |
-13.37% | 22.31B | |
-3.99% | 21.6B | |
-6.38% | 18.23B | |
-39.93% | 17.62B | |
+6.92% | 14.26B | |
+32.77% | 12.37B | |
-28.10% | 8.28B |
- Stock Market
- Equities
- LYEL Stock
- News Lyell Immunopharma, Inc.
- Lyell Immunopharma, Inc. Announce Resignation of Rahsaan Thompson as the Chief Legal Officer